Northern Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.12B | Sell |
8,827,564
-7,943
| -0.1% | -$8.05M | 1.07% | 12 |
|
|
2025
Q4 | $9.5B | Sell |
8,835,507
-63,528
| -0.7% | -$60.7M | 1.21% | 11 |
|
|
2025
Q3 | $6.79B | Sell |
8,899,035
-110,235
| -1% | -$82M | 0.87% | 13 |
|
|
2025
Q2 | $7.02B | Sell |
9,009,270
-164,208
| -2% | -$128M | 0.97% | 13 |
|
|
2025
Q1 | $7.58B | Sell |
9,173,478
-274,741
| -3% | -$229M | 1.12% | 12 |
|
|
2024
Q4 | $7.29B | Buy |
9,448,219
+1,204,337
| +15% | +$997M | 1.03% | 13 |
|
|
2024
Q3 | $7.3B | Sell |
8,243,882
-467,635
| -5% | -$420M | 1.2% | 10 |
|
|
2024
Q2 | $7.89B | Sell |
8,711,517
-123,936
| -1% | -$99.1M | 1.33% | 8 |
|
|
2024
Q1 | $6.87B | Sell |
8,835,453
-296,890
| -3% | -$211M | 1.19% | 9 |
|
|
2023
Q4 | $5.32B | Sell |
9,132,343
-1,025,932
| -10% | -$599M | 0.96% | 13 |
|
|
2023
Q3 | $5.46B | Buy |
10,158,275
+355,317
| +4% | +$183M | 1.06% | 11 |
|
|
2023
Q2 | $4.6B | Sell |
9,802,958
-687,502
| -7% | -$288M | 0.88% | 15 |
|
|
2023
Q1 | $3.6B | Sell |
10,490,460
-90,928
| -0.9% | -$30.7M | 0.71% | 20 |
|
|
2022
Q4 | $3.87B | Sell |
10,581,388
-127,805
| -1% | -$45.3M | 0.81% | 17 |
|
|
2022
Q3 | $3.46B | Sell |
10,709,193
-176,383
| -2% | -$55.9M | 0.79% | 16 |
|
|
2022
Q2 | $3.53B | Sell |
10,885,576
-382,159
| -3% | -$115M | 0.76% | 20 |
|
|
2022
Q1 | $3.23B | Sell |
11,267,735
-179,919
| -2% | -$46.3M | 0.57% | 24 |
|
|
2021
Q4 | $3.16B | Sell |
11,447,654
-38,076
| -0.3% | -$9.65M | 0.52% | 28 |
|
|
2021
Q3 | $2.65B | Buy |
11,485,730
+1,207,184
| +12% | +$298M | 0.47% | 35 |
|
|
2021
Q2 | $2.36B | Sell |
10,278,546
-72,459
| -0.7% | -$14.6M | 0.42% | 40 |
|
|
2021
Q1 | $1.93B | Sell |
10,351,005
-420,134
| -4% | -$82.2M | 0.36% | 51 |
|
|
2020
Q4 | $1.82B | Sell |
10,771,139
-231,509
| -2% | -$34.6M | 0.35% | 55 |
|
|
2020
Q3 | $1.63B | Sell |
11,002,648
-145,794
| -1% | -$22.6M | 0.36% | 57 |
|
|
2020
Q2 | $1.83B | Buy |
11,148,442
+226,212
| +2% | +$34.7M | 0.43% | 45 |
|
|
2020
Q1 | $1.52B | Sell |
10,922,230
-7,718
| -0.1% | -$1.06M | 0.44% | 46 |
|
|
2019
Q4 | $1.44B | Sell |
10,929,948
-110,635
| -1% | -$12.8M | 0.32% | 61 |
|
|
2019
Q3 | $1.23B | Sell |
11,040,583
-15,515
| -0.1% | -$1.73M | 0.3% | 61 |
|
|
2019
Q2 | $1.22B | Buy |
11,056,098
+32,421
| +0.3% | +$3.82M | 0.29% | 65 |
|
|
2019
Q1 | $1.43B | Sell |
11,023,677
-615,145
| -5% | -$74.8M | 0.35% | 57 |
|
|
2018
Q4 | $1.35B | Buy |
11,638,822
+416,787
| +4% | +$46.6M | 0.38% | 49 |
|
|
2018
Q3 | $1.2B | Sell |
11,222,035
-8,276
| -0.1% | -$827K | 0.29% | 64 |
|
|
2018
Q2 | $958M | Sell |
11,230,311
-72,186
| -0.6% | -$5.93M | 0.24% | 79 |
|
|
2018
Q1 | $874M | Sell |
11,302,497
-473,444
| -4% | -$38.1M | 0.23% | 87 |
|
|
2017
Q4 | $995M | Sell |
11,775,941
-265,813
| -2% | -$22.6M | 0.25% | 78 |
|
|
2017
Q3 | $1.03B | Buy |
12,041,754
+574,263
| +5% | +$47.1M | 0.27% | 72 |
|
|
2017
Q2 | $944M | Sell |
11,467,491
-128,875
| -1% | -$10.5M | 0.26% | 71 |
|
|
2017
Q1 | $975M | Buy |
11,596,366
+224,978
| +2% | +$18M | 0.28% | 68 |
|
|
2016
Q4 | $836M | Sell |
11,371,388
-179,266
| -2% | -$13.4M | 0.26% | 70 |
|
|
2016
Q3 | $927M | Buy |
11,550,654
+120,175
| +1% | +$9.62M | 0.29% | 67 |
|
|
2016
Q2 | $900M | Sell |
11,430,479
-15,008
| -0.1% | -$1.13M | 0.29% | 66 |
|
|
2016
Q1 | $829M | Sell |
11,445,487
-60,586
| -0.5% | -$4.58M | 0.27% | 69 |
|
|
2015
Q4 | $970M | Sell |
11,506,073
-678,310
| -6% | -$56.3M | 0.32% | 62 |
|
|
2015
Q3 | $1.02B | Sell |
12,184,383
-70,566
| -0.6% | -$5.96M | 0.34% | 55 |
|
|
2015
Q2 | $1.02B | Buy |
12,254,949
+586
| +0% | +$44.7K | 0.31% | 68 |
|
|
2015
Q1 | $890M | Sell |
12,254,363
-233,320
| -2% | -$16.6M | 0.27% | 75 |
|
|
2014
Q4 | $862M | Sell |
12,487,683
-290,019
| -2% | -$19.6M | 0.26% | 82 |
|
|
2014
Q3 | $829M | Sell |
12,777,702
-443,081
| -3% | -$28.1M | 0.26% | 80 |
|
|
2014
Q2 | $822M | Buy |
13,220,783
+252,915
| +2% | +$15.1M | 0.26% | 83 |
|
|
2014
Q1 | $763M | Sell |
12,967,868
-549,980
| -4% | -$30.7M | 0.24% | 87 |
|
|
2013
Q4 | $689M | Buy |
13,517,848
+159,989
| +1% | +$8.01M | 0.22% | 91 |
|
|
2013
Q3 | $672M | Sell |
13,357,859
-510,841
| -4% | -$26.7M | 0.24% | 87 |
|
|
2013
Q2 | $681M | Buy |
+13,868,700
| New | +$755M | 0.25% | 84 |
|
Other funds holding LLY
VCM
VPM
Northern Trust's LLY Position: Q1 2026 in Review
Northern Trust reduced its Eli Lilly (LLY) stake by 0.09% in Q1 2026, selling an estimated $8.05M and leaving 8,827,564 shares worth $8.12B. The position accounts for 1.07% of the portfolio, ranked #12.
Northern Trust first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.5B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Northern Trust held 8,827,564 shares of Eli Lilly worth $8.12B as of Q1 2026.
- Northern Trust sold 7,943 Eli Lilly shares in Q1 2026, an estimated $8.05M.
- Eli Lilly made up 1.07% of Northern Trust's portfolio in Q1 2026, its #12 holding.
- Northern Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Eli Lilly position peaked at $9.5B in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.